Edition:
United States

People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

42.31USD
24 Mar 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$42.31
Open
--
Day's High
--
Day's Low
--
Volume
5,400
Avg. Vol
3,619,352
52-wk High
$45.58
52-wk Low
$37.20

Dingemans, Simon 

Mr. Simon Dingemans is Chief Financial Officer, Executive Director of GlaxoSmithKline Plc. Prior to joining GSK, Simon had over 25 years of experience in investment banking at SG Warburg and Goldman Sachs. During this time, he advised a broad range of large corporates across a number of industry sectors, including pharmaceuticals and consumer healthcare. Simon advised GSK for over a decade before his appointment and was closely involved in a number of GSK’s key strategic projects.

Basic Compensation

Total Annual Compensation, GBP 1,707,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP 1,233,000
All Other, GBP 226,000
Fiscal Year Total, GBP 3,166,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --